Ansa Biotechnologies
1198 65th
St #250
Emeryville
CA
94608
United States
4 articles about Ansa Biotechnologies
-
Ansa Biotechnologies Announces First Shipments of Complex Clonal DNA Sequences to Customers in its Early Access Program
5/22/2023
Ansa Biotechnologies, Inc will present more information regarding these milestones at the SynBioBeta conference on Wednesday, May 24, 2023, at 11:46 a.m. PT.
-
Ansa Biotechnologies Announces Successful de novo Synthesis of World’s Longest Oligonucleotide at 1005 Bases
3/9/2023
Ansa Biotechnologies, Inc today announced the successful de novo synthesis of the world’s longest DNA oligonucleotide ever reported to be produced in a single synthesis.
-
Ansa Bio Appoints Dr. Matthew McManus as Chair of the Board
2/22/2023
Ansa Biotechnologies today announced the appointment of Matthew F. McManus, M.D, Ph.D., as Independent Director and Chairperson of the company’s Board of Directors.
-
BioSpace is proud to present its NextGen Bio “Class of 2023,” a list of the hottest recently launched life sciences companies in North America.